News
67. Chi KN, Rathkopf DE, Smith MR, et al: Phase 3 MAGNITUDE study: First results of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) as first-line therapy in patients (pts) with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback